BG17778A3 - - Google Patents

Info

Publication number
BG17778A3
BG17778A3 BG14436A BG1443670A BG17778A3 BG 17778 A3 BG17778 A3 BG 17778A3 BG 14436 A BG14436 A BG 14436A BG 1443670 A BG1443670 A BG 1443670A BG 17778 A3 BG17778 A3 BG 17778A3
Authority
BG
Bulgaria
Application number
BG14436A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691919570 external-priority patent/DE1919570B1/de
Priority claimed from DE19702000339 external-priority patent/DE2000339C3/de
Application filed filed Critical
Publication of BG17778A3 publication Critical patent/BG17778A3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG14436A 1969-04-17 1970-04-07 BG17778A3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19691919570 DE1919570B1 (de) 1969-04-17 1969-04-17 Isochinolinderivate
DE19702000339 DE2000339C3 (de) 1970-01-05 1970-01-05 Isochinolinderivate

Publications (1)

Publication Number Publication Date
BG17778A3 true BG17778A3 (fr) 1973-12-25

Family

ID=25757278

Family Applications (1)

Application Number Title Priority Date Filing Date
BG14436A BG17778A3 (fr) 1969-04-17 1970-04-07

Country Status (14)

Country Link
US (1) US3708486A (fr)
BE (1) BE748948A (fr)
BG (1) BG17778A3 (fr)
CS (1) CS162715B2 (fr)
ES (1) ES378672A1 (fr)
FR (1) FR2042341B1 (fr)
GB (1) GB1277847A (fr)
IE (1) IE34096B1 (fr)
IL (1) IL34328A (fr)
IT (1) IT7949558A0 (fr)
MY (1) MY7500210A (fr)
NL (1) NL146492B (fr)
RO (1) RO55588A (fr)
YU (1) YU34036B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7200696A (fr) * 1971-01-23 1972-07-25
DE2734222A1 (de) * 1977-07-29 1979-02-15 Thomae Gmbh Dr K Neue schwefelhaltige isochinolindione
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
AU2008232937B2 (en) 2007-03-30 2012-09-27 Ambrx, Inc. Modified FGF-21 polypeptides and their uses
JP6702962B2 (ja) 2014-10-24 2020-06-03 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 改変ｆｇｆ−２１ポリペプチドおよびその使用

Also Published As

Publication number Publication date
IT7949558A0 (it) 1979-06-27
IE34096L (en) 1970-10-17
YU34036B (en) 1978-10-31
GB1277847A (en) 1972-06-14
US3708486A (en) 1973-01-02
NL7005549A (fr) 1970-10-20
IE34096B1 (en) 1975-02-05
BE748948A (fr) 1970-10-14
ES378672A1 (es) 1975-06-01
YU91470A (en) 1978-05-15
RO55588A (fr) 1974-02-01
MY7500210A (en) 1975-12-31
NL146492B (nl) 1975-07-15
CS162715B2 (fr) 1975-07-15
FR2042341B1 (fr) 1974-05-24
IL34328A0 (en) 1970-06-17
IL34328A (en) 1973-05-31
FR2042341A1 (fr) 1971-02-12

Similar Documents

Publication Publication Date Title
AU465452B2 (fr)
AU450150B2 (fr)
FR2042341B1 (fr)
AU442375B2 (fr)
AU470301B1 (fr)
NO132198C (fr)
AU5113869A (fr)
AU442357B2 (fr)
AU442535B2 (fr)
AU442463B2 (fr)
AU442538B2 (fr)
AU442554B2 (fr)
AU442380B2 (fr)
SU399123A3 (fr)
AU5228269A (fr)
AU4540468A (fr)
AU5109569A (fr)
AU5077469A (fr)
AU4949169A (fr)
AU5066368A (fr)
CH40269A4 (fr)
AU5006968A (fr)
AU4982068A (fr)
BE737871A (fr)
BE738855A (fr)